REMIssion of Type 2 Diabetes Between Intermittently Scanned Continuous Glucose Monitoring and Capillary Blood Glucose Monitoring When Added to Low-calorie Meal Replacement and Diabetes Self-management Education
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 176 participants.
Also called NCT07157384
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 176 participants
- Registry
-
NCT07157384
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Canada
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07157384. Randomized; no masking; primary purpose treatment. Start 2025-09 (anticipated); primary completion 2027-03 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- REMIssion of Type 2 Diabetes Between Intermittently Scanned Continuous Glucose Monitoring and Capillary Blood Glucose Monitoring When Added to Low-calorie Meal Replacement and Diabetes Self-management Education
- Acronym
- REMIT2D isCGM
- Condition
- Type 2 Diabetes
- Intervention (Dietary supplement)
- Low calorie meal replacement plan
- Intervention (Behavioral)
- Diabetes self management education
- Intervention (Device)
- Intermittently scanned continuous glucose monitoring
- Intervention (Device)
- capillary blood glucose monitoring
- Lead sponsor
- LMC Diabetes & Endocrinology Ltd.
- Collaborator
- Abbott Diabetes Care
Record details
- Record id
cardio:ct-nct07157384- Content hash
f815b6cb00d6be1e678444b85195db7c04001f473d686652d667a0af4ff614dd